Genetic Testing to Guide Warfarin Dosing: Impact of Direct Oral Anticoagulants

被引：4
|
作者：
Lentz, S. R. [1 ]
机构：
[1] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 100卷 / 02期
关键词：
PHARMACOGENETICS; GENOTYPES;
D O I：
10.1002/cpt.395
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Despite rapid growth in the use of direct oral anticoagulants (DOACs), warfarin remains a widely prescribed anticoagulant drug. It is likely that the overall use of warfarin will continue to decline, but not completely disappear, as indications for DOACs expand. This changing anticoagulation landscape, along with the likelihood that personalized genomic information will become increasingly available, has several implications for the future of warfarin dosing strategies.
引用
收藏
页码：128 / 130
页数：4
相关论文
共 50 条
  • [41] DOSING ACCURACY OF DIRECT ORAL ANTICOAGULANTS: THE EFFECT OF AN EDUCATIONAL INTERVENTION
    Balachandran, S.
    Valentine, L.
    Tse, G.
    Fanning, L.
    Dewey, H.
    Choi, P. M.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 10 - 10
  • [42] Thrombophilia testing in the era of direct oral anticoagulants
    Darlow, Jennifer
    Mould, Holly
    CLINICAL MEDICINE, 2021, 21 (05) : E487 - E491
  • [43] Direct oral anticoagulants: a practical guide for the emergency physician
    Hogg, Kerstin
    Panag, Ajit
    Worster, Andrew
    Thachil, Jecko
    EUROPEAN JOURNAL OF EMERGENCY MEDICINE, 2016, 23 (05) : 330 - 336
  • [44] Genetic testing for warfarin dosing? Not yet ready for prime time
    Bussey, Henry I.
    Wittkowsky, Ann K.
    Hylek, Elaine M.
    Walker, Marie B.
    PHARMACOTHERAPY, 2008, 28 (02): : 141 - 143
  • [45] Oral anticoagulants:: warfarin or acenocumarol?
    Roncales, Francisco Javier
    MEDICINA CLINICA, 2008, 131 (03): : 98 - 100
  • [46] Direct oral anticoagulants versus warfarin for the treatment of left ventricular thrombosis
    Alexandra Evaun Mihm
    Harry Eugene Hicklin
    Alexandra Lee Cunha
    Sarah Anne Nisly
    Kyle Andrew Davis
    Internal and Emergency Medicine, 2021, 16 : 2313 - 2317
  • [47] Assessing patient preferences for switching from warfarin to direct oral anticoagulants
    Jack N. Wright
    Sara R. Vazquez
    Kibum Kim
    Aubrey E. Jones
    Daniel M. Witt
    Journal of Thrombosis and Thrombolysis, 2019, 48 : 596 - 602
  • [48] Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants
    Lee, Jeffrey
    Kong, Xiaowen
    Haymart, Brian
    Kline-Rogers, Eva
    Kaatz, Scott
    Shah, Vinay
    Ali, Mona A.
    Kozlowski, Jay
    Froehlich, James
    Barnes, Geoffrey D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (11) : 2571 - 2578
  • [49] Direct oral anticoagulants compared with warfarin in patients with severe blunt trauma
    Feeney, James M.
    Neulander, Matthew
    DiFiori, Monica
    Kis, Lilla
    Shapiro, David S.
    Jayaraman, Vijay
    Marshall, William T., III
    Montgomery, Stephanie C.
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2017, 48 (01): : 47 - 50
  • [50] COMPARING OUTCOMES AMONG DIRECT ORAL ANTICOAGULANTS AND WARFARIN IN CIRRHOTIC PATIENTS
    Joseph, Joel
    Davis, Kyle
    Nisly, Sarah
    GASTROENTEROLOGY, 2020, 158 (06) : S1468 - S1468
12345